Outcome of liver transplantation with grafts from DBD donors treated with D-HOPE

Clinical Evidence

Outcome of liver transplantation with grafts from DBD donors treated with D-HOPE

Outcome of liver transplantation with grafts from DBD donors treated with D-HOPE

In a single center, retrospective cohort study by Patrono et al., they sought to compare the effects of dual hypothermic oxygenated machine perfusion (D-HOPE) and static cold storage (SCS) on graft survival in liver transplant with grafts from extended criteria donation after brain death (ECD-DBD) grafts. This trial included 844 patients (121 D-HOPE and 723 SCS) with a primary outcome of early allograft failure (EAF), as defined by listing for retransplantation or patient death for any cause within 90 days of transplant.

Their results found:

  • D-HOPE was associated with a significant reduction of:
    • EAF (OR:0.24)
    • Dindo-Clavien grade ≥3 complications (OR: 0.57)
    • Comprehensive complication index (mean reduction 7.20 points)
  • Ischemic cholangiopathy severity was significantly lower in the D-HOPE group
  • D-HOPE had a significant improvement in both graft and patient survival

Overall, they concluded that this study showed D-HOPE of livers from DBD donors is associated with a significant reduction of postoperative complications and EAF, leading to improved patient and graft survival.  They indicated that their findings prompt a wider adoption of D-HOPE in clinical practice.

Read the full article here: https://doi.org/10.1111/ajt.16996

Tagged In:

Clinical, ECD, Graft Survival, HMP, Liver

The Latest

Check out the most recent posts

Strengthening the Transplant Ecosystem

By Perry Turner, Managing Director, Commercial & Clinical Operations Organ donation and transplantation is an intricate process that extends far beyond operating rooms and hospitals. Successful transplants are carefully coordinated and planned, requiring close...

James, Senior Vice President, Operations and R&D

James, Senior Vice President, Operations and R&D

I recently joined Organ Recovery Systems as Senior Vice President of Operations and R&D, where I am responsible for driving innovation and operational excellence across the organization. I was drawn to ORS by the opportunity to work alongside a talented team...